Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
23538 | 288 | 29.4 | 55% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INHALED FUROSEMIDE | Author keyword | 4 | 75% | 1% | 3 |
2 | ULTRASONICALLY NEBULIZED DISTILLED WATER INHALATION CHALLENGE | Author keyword | 3 | 100% | 1% | 3 |
3 | FRUSEMIDE | Author keyword | 3 | 13% | 6% | 18 |
4 | HISTAMINE INHALATION CHALLENGE | Author keyword | 1 | 50% | 1% | 2 |
5 | RELATIVE COLLAGEN CONTENT | Author keyword | 1 | 100% | 1% | 2 |
6 | LYSINE ACETYLSALICYLATE | Author keyword | 1 | 17% | 1% | 4 |
7 | AFFERENT VAGAL NERVE ACTIVITY | Author keyword | 1 | 50% | 0% | 1 |
8 | CANTABRIA HLTH SERV | Address | 1 | 50% | 0% | 1 |
9 | CAROTID VASCULAR BED | Author keyword | 1 | 50% | 0% | 1 |
10 | ISCHAEMIC HEART DISEASES | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INHALED FUROSEMIDE | 39 | 50% | 19% | 56 |
2 | FRUSEMIDE | 18 | 25% | 22% | 62 |
3 | METHACHOLINE INDUCED BRONCHOCONSTRICTION | 6 | 20% | 9% | 27 |
4 | LOOP DIURETICS | 3 | 11% | 10% | 29 |
5 | BRONCHIAL RESPONSE | 3 | 33% | 3% | 8 |
6 | METABISULFITE INDUCED BRONCHOCONSTRICTION | 3 | 37% | 2% | 7 |
7 | CHRONIC BRONCHOPULMONARY DYSPLASIA | 2 | 26% | 2% | 5 |
8 | ACUTE VASCULAR RESPONSES | 1 | 100% | 1% | 2 |
9 | INHALED FUROSEMIDE PREVENTS | 1 | 100% | 1% | 2 |
10 | ACETYLSALICYLATE L ASA | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Nebulized furosemide for the management of dyspnea: Does the evidence support its use? | 2008 | 13 | 51 | 76% |
Aerosolized diuretics for preterm infants with (or developing) chronic lung disease | 2006 | 19 | 25 | 56% |
Furosemide protective effect against airway obstruction | 2002 | 8 | 41 | 76% |
INHALED LOOP DIURETICS AS POTENTIAL NEW ANTIASTHMATIC DRUGS | 1993 | 27 | 19 | 63% |
Vascular effects of loop diuretics | 1996 | 33 | 39 | 38% |
FUROSEMIDE AND LOOP DIURETICS IN HUMAN ASTHMA | 1994 | 16 | 40 | 55% |
Unexpected extra-renal effects of loop diuretics in the preterm neonate | 2012 | 1 | 61 | 20% |
LOOP DIURETICS AND ASTHMA | 1992 | 20 | 31 | 35% |
The pharmacologic spectrum of furosemide | 2008 | 4 | 105 | 18% |
FUROSEMIDE ATTENUATES BRONCHIAL RESPONSIVENESS TO ANTIGEN CHALLENGE IN-VITRO | 1995 | 0 | 4 | 50% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANTABRIA HLTH SERV | 1 | 50% | 0.3% | 1 |
2 | MEM MILLER CHILDRENS HOSP | 1 | 50% | 0.3% | 1 |
3 | ALLERGY IMMUNOL PULM | 0 | 33% | 0.3% | 1 |
4 | EAR NOSE THROAT CLIN 3 | 0 | 33% | 0.3% | 1 |
5 | PCEBM | 0 | 13% | 0.7% | 2 |
6 | INTENS CARE MED 519 | 0 | 17% | 0.3% | 1 |
7 | ADV PHARMACEUT | 0 | 14% | 0.3% | 1 |
8 | BIBLIOTECA | 0 | 14% | 0.3% | 1 |
9 | CONICETIQUIMEFA | 0 | 11% | 0.3% | 1 |
10 | INTERNAL DIS ALLERGOL | 0 | 11% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000181238 | TORASEMIDE//TORSEMIDE//FUROSEMIDE |
2 | 0.0000150308 | TRANSEPITHELIAL ELECTRICAL POTENTIAL DIFFERENCE//PATHOBIOCHEM CLIN CHEM//SWEAT GLAND |
3 | 0.0000130177 | STEROID DEPENDENT ASTHMA//STEROID SPARING AGENTS//ALLERGY P CARE |
4 | 0.0000107304 | EXERCISE INDUCED ASTHMA//EXERCISE INDUCED BRONCHOCONSTRICTION//EXERCISE INDUCED BRONCHOSPASM |
5 | 0.0000104602 | WNK//MOL PHYSIOL UNIT//WNK4 |
6 | 0.0000093586 | SNGFR//LITHIUM CLEARANCE//GLOMERULO TUBULAR BALANCE |
7 | 0.0000078580 | ENVIRONM MED TOXICOL//SODIUM METABISULFITE//SULFUR DIOXIDE DERIVATIVES |
8 | 0.0000075857 | NEDOCROMIL SODIUM//SODIUM CROMOGLYCATE//CROMOLYN SODIUM |
9 | 0.0000073015 | PRACTICE POINTS//RENAL PROSTANOIDS//PAH CLEARANCE |
10 | 0.0000072064 | EPITHELIUM DERIVED RELAXING FACTOR//COAXIAL BIOASSAY//EPITHELIUM DERIVED INHIBITORY FACTOR EPDIF |